INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA

Clinical trials for INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA trials appear

Sign up with your email to follow new studies for INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to outperform standard care for advanced liver cancer

Disease control Recruiting now

This Phase 3 trial tests whether a chemotherapy infusion directly into the liver (HAIC) plus immunotherapy drugs works better than the standard chemo-embolization procedure (TACE) plus the same immunotherapy for people with intermediate-stage liver cancer that has spread extensiv…

Matched conditions: INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA

Phase: PHASE3 • Sponsor: Binkui Li • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC

INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA

Get alerted when new INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA trials appear

New combo therapy aims to outperform standard care for advanced liver cancer